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Conclusion: PORT for tongue cancer without intraoral stent is 
best planned with the target volume extending towards the 
palate to allow for inter-fractional movement of the tongue. 
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Purpose or Objective: Anatomical changes taking place over 
the course of radiation therapy (RT) result in a difference 
between planned and delivered dose. For pancreatic cancer, 
we investigated the robustness of clinical treatment plans by 
quantifying the dosimetric effects of changes in gas volumes, 
body contour and interfractional target displacement. In 
addition, we compared the dosimetric effect of anatomical 
changes between use of bony anatomy and use of 
intratumoral fiducial markers for patient positioning. 
 
Material and Methods: Nine pancreatic cancer patients were 
included who had intratumoral markers for daily cone-beam 
CT (CBCT)-based position verification. The clinical plans (10 
MV; 1 arc VMAT; internal CTV (iCTV) to PTV margin = 10 mm) 
were used for dose calculation. To enable fraction dose 
calculations on CBCT, the planning CT was deformably 
registered to each CBCT (13–15 CBCTs per patient); air 
volumes visible on the CBCT were copied to the deformed 
CT.  
Calculations were done for marker-based registration (as 
clinically used) and for bony anatomy-based registration. For 
both methods, doses were rigidly summed to yield the 
accumulated doses on the planning CT. For each patient, all 
DVHs were normalized to yield for the planned dose to the 
PTV: V98% = 95% (100% = 36 Gy).  
To evaluate target coverage, we defined an iCTV+5mm 
volume, i.e. the iCTV expanded with a 5 mm margin to 
account for remaining uncertainties including delineation. We 
analysed D98%, Dmean and D2% for iCTV+5mm and iCTV and 
examined DVH differences for duodenum and stomach, the 
organs at risk closest to the iCTV. 
 
Results: For the iCTV+5mm, D98% changed from mean 96.3% 
(range 95.5–97.8%) for the planned dose to 96.7% (96.4–
97.0%) for marker-based accumulated dose (Table 1).  
 
 
 
These relatively small differences indicate a limited 
dosimetric effect from changes in gas and body contour, even 
though the amount of gas visible on CBCT showed large 
variations (avg. 166 ml, SD 145 ml).  
In contrast, D98% decreased to 95.3% (85.8–97.9%) for bony 
anatomy registration, due to systematic errors inherently 
associated with bony-anatomy patient positioning. Changes 
for stomach and duodenum depended strongly on the 
direction of these errors, with large increases in D2% for 
some (error in direction of organ) and large decreases for 
others. Differences were largest for the stomach (e.g. D2% 
from 72.7% (planned) to 82.4% (bony anatomy-based 
accumulated)). For marker-based positioning, the dosimetric 
effects for stomach and duodenum were limited (<0.5 Gy in 8 
out of 9 patients). 
 
Conclusion: Photon irradiation of pancreatic tumours is 
robust to variations in body contour and gastrointestinal gas, 
with dose coverage only mildly affected by these anatomical 
changes. However, when using bony anatomy for patient 
positioning, dose coverage declines due to interfractional 
tumour position variations. Therefore, the use of fiducial 
marker-based daily position verification is essential in RT for 
pancreatic cancer. 
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Purpose or Objective: Patients undergoing prostate intensity 
modulated arc therapy (IMAT) were retrospectively 
investigated using the CBCT images acquired for setup 
purposes to determine the volumetric variability of the target 
and organs at risk and the dosimetric implications of these 
changes. 
 
Material and Methods: IMAT plans from 11 patients were 
designed to deliver 74 Gy in 37 fractions to the target. The 
CTV consisted of the prostate and seminal vesicles, while the 
PTV was the CTV plus a margin of 10 mm in all directions 
except posteriorly, where a 5 mm margin was used. For 
between 9 and 14 of the 37 fractions, the patients were 
scanned using an on-board CBCT imager to verify the setup. 
These images were retrospectively registered to the planning 
CT using an in-house registration algorithm to determine the 
transformations between the images. The calculated 
transformation vector field was used to deform the planning 
CT so that the plan could be recalculated with the original 
MU on this new adapted CT. This allowed the determination 
of the dosimetric impact of the change in anatomical 
information from the time of acquisition of the planning CT 
to immediately prior to a given treatment fraction. The 
imaged fractions were treated as though they were 
representative of the entire treatment and were weighted 
equally for dose accumulation purposes. 
 
Results: Over the course of the patients’ treatments, the 
changes in CTV volume compared to the plan were from a 
decrease of 25% up to a maximum increase of 6%. Their 
bladder volumes ranged from -10% to 10% of their respective 
volumes on the planning CT. The rectal volume decreased for 
all patients, with 5% less than the planning volume the 
smallest reduction and 34% being the largest volume 
shrinkage. 
The dosimetric impact of these anatomical changes varied for 
each structure. The minimum dose received by the CTV 
varied by less than 1% for all patients, with full coverage of 
the CTV achieved in all fractions. 
The mean dose delivered to the bladder averaged over each 
patients treatment resulted in variation of between -4% and 
17% of their respective planned mean doses. This did not 
result in a break of the dose-volume constraints (DVCs) for 
the bladder at any fraction, for any patient. 
The rectum received a higher mean dose than the planned 
value for all patients. This ranged from an increase of 7% up 
to 38%. It was found that the rectum frequently broke 
multiple DVCs, resulting in the rectum being overdosed in 
79% of the fractions examined. 
 
Conclusion: Analysis of the anatomical condition of the 
patient on the day of treatment can give an indication of how 
suitable the original plan for their treatment is. For these 
patients, although the variability in the anatomy did not 
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result in any significant under-dosing of the target, the 
observed differences showed that the rectum broke our 
institutional DVCs during treatment. This is important data 
required to evaluate the robustness of institutional 
procedures for the planning and delivery of patients’ 
treatments. 
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Purpose or Objective: Acceleration in breast cancer 
treatment might become the new standard. As fraction dose 
rises, the importance of correct positioning increases. CBCT 
is time consuming and uses (low dose) radiation. Increasing 
interval between positioning and actual treatment reduces 
precision. We therefore investigated a CBCT technique with 
lower dose and faster acquisition.  
 
Material and Methods: Both standard and fast pre-treatment 
CBCT imaging (STAND and FAST) were performed on XVI 
Elekta ® in a 5-fractions supine and whole breast irradiation 
scheme (5 x 5.7 Gy). The main difference between protocols 
was gantry speed (Table 1). Central dose was measured with 
PTW equipment in a CTDI32 phantom. High resolution (HR) 
and contrast were measured on a Catphan Phantom. Breast 
contour appearance was assessed on a polystyrene breast 
phantom. Fifteen clinical CBCT-images for three patients to 
which FAST or STAND was randomly assigned, were blindly 
scored by a skilled oncologist. A three-level answer had to be 
formulated regarding visibility of 1) all clips, 2) entire breast 
contour, 3) lung/thorax wall edge and 4) excision cavity. 
Answers were decoded: 0: Not at all; 1: Yes, but only with 
guidance of reference CT; 2; Yes clearly, without reference 
CT. 
 
Results: FAST operated at only 53% and 61 % of dose and time 
of STAND. A low HR (3 lp/mm) was the same for FAST and 
STAND. Contrast was assessed for STAND through visibility of 
the largest (15mm) 1% contrast nodule. For FAST, no nodules 
could be distinguished. There was excess-tissue on cranial 
and caudal CBCT breast phantom slices, but to the same 
extent in STAND and FAST. In mid position, breast edge was 
sharp and coincided with reference CT.  
The Patient study reflected a difference in the overall low 
soft tissue contrast for the two protocols. The excision cavity 
was never scored 2, more 1 for STAND and more 0 for FAST 
and was less visible with higher breast density (patient 3). 
Breast contours showed step-wise artifacts near 
inframammary and axillary folds for both protocols. 
Lung/thorax wall edges were scored 2 and 1 but the 
dependency was larger for patient anatomy than for scan 
protocol. All clips were visible: the rather poor HR is however 
sufficient. Streak artifacts due to beam hardening and 
undersampling were apparent in both protocols (Figure 1).  
Even though the noisy and artifact-rich appearance of the 
images, effect on clinical decision making for registration is 
minimal. The stepwise artifacts appear very localized and are 
easily corrected for in the observer’s mind. Additional 
information by outer breast contour and lung-thoracic wall 
edge compensates for this. Distinction between real artifacts 
and excision cavity can be done by comparison with 
reference CT. Clips are always visible and of special 
importance in high density and/or voluminous breasts. 
 
 
 
 
Conclusion: FAST allows the oncologist to register breast 
CBCT. However, with high density or voluminous breasts, 
clips are recommended with the use of FAST. 
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Purpose or Objective: The primary goal of this study was to 
evaluate the residual inter-fraction positioning errors of our 
intra-cranial frameless stereotactic treatment following a six-
degree of freedom (6DOF) correction based on automatic 
bone anatomy matching. A secondary goal was to evaluate 
the intra-fraction motion. 
 
Material and Methods: Since the implementation of the 
stereotactic program at our centre, 13 patients were treated 
with frameless intra-cranial fractionated radiotherapy on a 
Varian TrueBeam STx linear accelerator. All patients had a 
planning CT scan with an immobilization system that 
comprised of a CIVCO head cup, customizable pillow and 
thermoplastic shell. To guide setup, nose to forehead pitch 
was calculated using CT information and reproduced at 
treatment using a digital level. Roll was measured as the 
difference in height at the level of the anterior ear notch and 
reproduced at treatment using the in-room lasers. Two pre-
treatment CBCTs were acquired; the first to correct using 
6DOF bone anatomy matching the initial inter-fraction 
positioning error and the second to assess the residual inter-
fraction error post 6DOF correction. Since our initial 
experience with the first 3 patients, revealed residual inter-
fraction setup errors greater than 1mm, the residual inter-
fraction setup error post 6DOF correction was measured and 
corrected prior each treatment for all remaining 10 patients. 
Due to the technical limitations of Varian’s 6DOF couch (i.e. 
maximum 3 degrees pitch and roll), the correction of the 
residual inter-fraction error was carried out using 4DOF 
automatic bony anatomy matching (i.e. excluding pitch and 
roll due to 3degree limitation). A post-treatment CBCT was 
acquired to determine the intra-fraction motion using 6DOF 
bone anatomy matching. 
 
